XML 64 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restatement
6 Months Ended 12 Months Ended
Jun. 30, 2015
Dec. 31, 2014
Restatement [Abstract]    
RESTATEMENT

NOTE 5 – RESTATEMENT

 

We restated our financial statements to correct the way we accounted for certain items related to stock based compensation, revenue share expense, and revenue recognition. The full impact of the restatement was reflected in the December 31, 2014 financial statements at the end of the year. The table below reflects the impact on the 2014 period reflected in this report.

 

The restated Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the three and six months ended June 30, 2014, as applicable, is as follows:

 

Three months ended June 30, 2014    Previously 
Financial Statement Line Item Corrected  Stated 
Income statement Revenue  1,426,808   1,454,214 
Income statement Cost of Sales $730,140  $540,048 
Income statement Operating expenses  896,529   967,070 
Income statement Loss from operations $(199,861) $(52,904)
Income statement Loss before income taxes $(199,638) $(52,681)
Income statement Net loss $(199,638) $(52,681)

  

Six months ended June 30, 2014    Previously 
Financial Statement Line Item Corrected  Stated 
Income statement Revenue  2,716,236   2,771,560 
Income statement Cost of Sales $1,291,551  $1,038,858 
Income statement Operating expenses  2,386,747   2,439,028 
Income statement Loss from operations $(962,062) $(706,326)
Income statement Loss before income taxes $(961,733) $(705,996)
Income statement Net loss $(961,733) $(705,996)
Statement of cash flows Net loss $(961,733) $(705,996)
Statement of cash flows Stock and options issued for services $627,344  $654,634 
Statement of cash flows Increase in accounts payable $203,714  $173,889 
Statement of cash flows Decrease in revenue share payable $(311,776) $(686,760)
Statement of cash flows Increase in deferred revenue $19,651  $38,656 
 

NOTE 17 – RESTATEMENT

 

The Company discovered and recorded items requiring it to restate its 2013 financial results, as well as its 2014 quarterly results, to correct the accounting for certain transactions contained therein. The restatement relates to unrecorded stock compensation related to investor relations and consulting services, unrecorded revenue share payables, and changes in revenue recognition, all occurring during the year ended December 31, 2013. The revenue recognition relates to promotional programs started in 2013 that were expected to be completed in 2013, but actually carried over into 2014.

 

The following items were restated in the 2013 Annual Financial Statements

 

Balance Sheet  Previously stated   Adjustments   Restated 
Accounts receivable $1,566,964  $(55,255) $1,511,709 
Revenue share payable $1,193,661  $93,891  $1,287,552 
Deferred revenue $4,252  $222,020  $226,272 
Additional paid in capital $8,726,708  $148,477  $8,875,155 
Deferred stock compensation $(233,942) $(36,520) $(270,462)
Accumulated deficit $(24,616,220) $(483,137) $(25,099,357)
             
Statement of Operations            
Revenue $4,957,016  $(277,275) $4,679,741 
Revenue share expense $1,767,425  $93,891  $1,861,316 
Operating expenses $2,973,990  $111,701  $3,085,691 
Net income (loss) $215,847  $(483,137) $(267,290)
             
Statement of Cash Flows            
Net income (loss) $215,847  $(483,137) $(267,290)
Stock options issued for services $19,547  $75,451  $94,998 
Stock-based compensation $399,092  $36,520  $435,612 
Changes in accounts receivable $(950,166) $55,255  $(894,911)
Changes in revenue share payable $1,103,084  $93,891  $1,196,975 
Changes in deferred revenue $(45,000) $222,020  $177,020 


 

The following tables show the effect of the restatement on the unaudited quarterly information previously filed.

 

Period Ended September 30, 2013 (unaudited):

 

Balance Sheet Previously stated  Adjustments  Restated 
             
Revenue share payable $782,902  $28,376  $811,278 
Deferred revenue $13,272  $147,860  $161,132 
Additional paid in capital $8,449,271  $148,477  $8,597,748 
Deferred stock compensation $(233,077) $(54,780) $(287,857)
Accumulated deficit $(24,870,854) $(270,207) $(25,141,061)
             
Statement of Operations            
Three Months ended September 30, 2013            
Revenue $1,373,029  $(147,860) $1,225,169 
Revenue share expense $529,134  $28,376  $557,510 
Operating expenses $982,504  $93,971  $1,076,475 
Net income (loss) $(141,527) $(270,207) $(411,734)
Nine Months ended September 30, 2013            
Revenue $3,146,406  $(147,860) $2,998,546 
Revenue share expense $1,264,059  $28,376  $1,292,435 
Operating expenses $2,272,239  $93,971  $2,366,210 
Net income (loss) $(389,716) $(270,207) $(659,923)
             
Statement of Cash Flows            
Net income (loss) $(389,716) $(270,207) $(659,923)
Stock-based compensation $310,823  $93,971  $404,794 
Changes in revenue share payable $649,825  $28,376  $678,201 
Changes in deferred revenue $(35,980) $147,860  $111,880 

 

Period Ended March 31, 2014 (unaudited):

 

Balance Sheet Previously stated  Adjustments  Restated 
             
Revenue share payable $797,725  $167,880  $965,605 
Deferred revenue $168,714  $268,807  $437,521 
Additional paid in capital $27,155,730  $148,477  $27,304,207 
Deferred stock compensation $(454,409) $(18,260) $(472,669)
Accumulated deficit $(25,269,535) $(591,917) $(25,861,452)
             
Statement of Operations            
Three Months ended March 31, 2014            
Revenue $1,317,347  $(27,919)  $1,289,428 
Revenue share expense $498,810  $62,601  $561,411 
Operating expenses $1,471,598  $18,260  $1,489,858 
Net income (loss) $(653,315) $(108,780) $(762,095)
             
Statement of Cash Flows            
Net income (loss) $(653,315) $(108,780) $(762,095)
Stock-based compensation $361,957  $18,260  $380,217 
Changes in revenue share payable $(395,935) $62,601  $(333,334)
Changes in deferred revenue $164,462  $27,919  $192,381 

 

 

Period Ended June 30, 2014 (unaudited):

 

Balance Sheet Previously stated  Adjustments  Restated 
             
Revenue share payable $506,901  $366,088  $872,989 
Deferred revenue $42,908  $258,270  $301,178 
Additional paid in capital $27,304,112  $84,677  $27,388,789 
Accumulated deficit $(25,322,216) $(738,674) $26,060,890)
             
Statement of Operations            
Three Months ended June 30, 2014            
Revenue $1,454,214  $(27,206) $1,427,008 
Revenue share expense $540,048  $190,092  $730,140 
Operating expenses $967,070  $(70,541) $896,529 
Net income (loss) $(52,681) $(146,757) $(199,438)
             
Six Months ended June 30, 2014            
Revenue $2,771,560  $(55,124) $2,716,436 
Revenue share expense $1,038,858  $252,693  $1,291,551 
Operating expenses $2,439,028  $(52,281) $2,386,747 
Net income (loss) $(705,996) $(255,537) $(961,533)
             
Statement of Cash Flows            
Net income (loss) $(705,996) $(255,537) $(961,533)
Stock-based compensation $654,634  $(52,281) $602,353 
Changes in revenue share payable $(686,760) $252,693  $(434,067)
Changes in deferred revenue $38,656  $55,124  $93,780 

 

 

Period Ended September 30, 2014(unaudited):

 

Balance Sheet Previously stated  Adjustments  Restated 
             
Revenue share payable $853,410  $421,019  $1,274,429 
Deferred revenue $-0-  $118,949  $118,949 
Additional paid in capital $28,398,825  $84,677  $28,483,502 
Accumulated deficit $(25,716,530) $(638,903) $(26,355,433)
             
             
Statement of Operations            
Three Months ended September 30, 2014            
Revenue $1,620,215  $199,206  $1,819,421 
Revenue share expense $858,898  $99,435  $958,,333 
Operating expenses $1,155,933  $-0-  $1,155,933 
Net income (loss) $(394,314) $99,771  $(294,543)
             
Nine Months ended September 30, 2014            
Revenue $4,391,775  $144,082  $4,535,857 
Revenue share expense $1,897,757  $352,127  $2,249,884 
Operating expenses $3,594,961  $(52,280) $3,542,681 
Net income (loss) $(1,100,310) $(155,766) $(1,256,076)
             
Statement of Cash Flows            
Net income (loss) $(1,100,310) $(155,766) $(1,256,076)
Stock-based compensation $1,118,952  $(52,280) $(1,066,672)
Changes in revenue share payable $(340,251) $352,127  $11,876 
Changes in deferred revenue $(4,252) $(144,082) $(148,334)